introduction body composed mucosal organ specialized goblet cell mucous cell aligned epithelium integrated intercellular epithelial junction apical surface covered glycocalyx matrix basically separating body environment trapping influx noxious stimulus innate immune cell antibody antimicrobial molecule contained mucosal layer counteract invader initiating adaptive immunity moreover mucosal organ harbor distinct microbiota actively interact barrier component maturate host system gut lung representative mucosal organ sharing structural functional similarity proper mucus production essential sustain steady-state epithelial integrity microbial homeostasis organ therefore association gut lung gut–lung axis interesting studied extensively recent time concerning pathogenesis inflammatory disease gut lung display disrupted homeostasis resulting mucosal inflammation loss barrier integrity dysbiosis especially loss epithelial integrity trigger exacerbation disease due influx allergen excess inflammatory cell mediator leading mucosal barrier damage thereby increased intestinal permeability one representative feature inflammatory bowel disease ibd case airway inflammation inhaled harmful factor disrupt barrier integrity connecting allergen sensitization loss dysfunction epithelial tight junction observed asthmatic patient based use probiotic proposed one novel future strategy probiotic defined living microorganism administered adequate amount confer health benefit host probiotic strain belong lactic acid bacteria lab especially genus lactobacillus bifidobacterium often isolated fermented food strain lactobacillus sakei used food industry natural preservative starter culture recently aspect immunomodulators sakei highlighted ameliorative effect chronic inflammatory disease mucosal site reported likewise several sakei strain showed potential putative probiotic immune system regulation microbiota modulation barrier reinforcement recently several researcher attempted expand application sakei strain distal part pulmonary system however research sakei strain still required based previous study study aimed investigate novel safe sakei strain fermented food confirm probiotic potential vitro vivo model specially targeting gut lung mucosal environment material method isolation korean fermented kimchi 4.48 sample homogenized lonza switzerland followed serial dilution plating man rogosa sharpe becton dickinson company usa incubation anaerobic condition colony selected isolation purification first potassium hydroxide koh test conducted drop koh solution placed slide colony pure culture selected mixed koh solution resulting bacterial suspension exhibit viscous characteristic suggesting isolated strain gram-positive subsequently picked colony exposed drop hydrogen peroxide solution absence bubble upon reaction confirmed isolated strain catalase negative rrna sequencing carried solgent inc daejeon republic korea bacterial dna isolated using boiling method chelex bead bio-rad usa amplification rrna gene achieved pcr utilizing solg™ ef-taq dna polymerase solgent inc universal primer 27f aga gtt tga tcc tgg ctc 1492r ggt tac ctt gtt acg act employed pcr reaction conducted verti 96-well thermal cycler thermo fischer scientific usa following cycling condition cycle min initial denaturation cycle denaturation cycle annealing cycle min extension followed cycle min final extension sequencing executed using abi prism 3730xl dna analyzer applied biosystems usa homologous sequence obtained result identified using basic local alignment search tool blast genbank bacteria sakei hem rhamnosus grown agar broth pathogenic control hemolysis biogenic amine production assay escherichia coli atcc bacillus cereus atcc used strain cultured brain heart infusion bhi medium agitation whole genome sequencing complete genome sequence sakei hem generated using pacbio platform single molecule real-time smrt sequencing theragenetex inc. seoul republic korea commercial service briefly sakei hem cultured agar previously described bacterial dna extracted fresh pellet using wizard genomic dna purification kit promega thermo fischer scientific subsequently library prepared paired-end sequencing using truseq nano dna sample prep kit illumina usa sequencing conducted paired-end illumina novaseq platform following smrt library preparation sequencing draft genome assembled using canu v.1.7 annotation performed merging result obtained rapid annotation using subsystem technology rast server hemolysis bacterial culture grown streaked onto blood agar plate containing sheep blood hanil komed republic korea followed incubation hemolysin production determined observation clear zone formation biogenic amine formation sakei hem cultured special medium modification briefly precursor amino acid -tyrosine samchun chemical republic korea -histidine daejung chemical republic korea -ornithine sigma-aldrich -lysine samchun chemical included decarboxylase medium determine production tyramine histamine putrescine cadaverine production ability identified color change indicator bromocresol purple medium antibiotic susceptibility agar diffusion method used determine antibiotic susceptibility strain suggested clinical laboratory standard institute clsi http and/or efsa method previously described introduced modification two-fold serial dilution antibiotic solution prepared suspended iso-sensitest mixture agar oxoid bacterial suspension adjusted desired concentration cfu/ml cfu/ml inoculated onto plate using multipin-inoculator plate incubated anaerobic condition antibiotic resistance determined higher concentration specific antimicrobial cut-off value according european food safety authority presence acquired antimicrobial resistance gene whole-genome data identified using resfinder program http simulated stomach duodenum passage ssdp assay performed previously described strain ssdp inoculated level broth 3.0 incubated incubation duodenum juice nahco3 6.4 g/l kcl 0.239 g/l nacl 1.28 g/l bile acid oxgall added promptly medium incubated two additional hour viable colony counted cell adhesion caco-2 human colorectal epithelial cell-line korean cell line bank republic korea grown minimum essential medium eagle mem corning usa supplemented fetal bovine serum gibco™ usa antibiotic antibiotic–antimycotic gibco™ non-essential amino acid solution gibco™ 36.5 environment cell cells/well seeded well plate maintained confluency bacteria cell adhesion assay conducted according previous protocol modification briefly sakei hem bacterial cell cells/well harvested washed incubation following resuspension mem caco-2 cell washed remove antibiotic bacterial suspension treated ratio 100:1 bacterial cell caco-2 cell co-incubation number attached bacteria counted agar plate incubation vivo dss-induced colitis model seven-week-old female c57bl/6j mouse purchased central laboratory animal inc. seoul republic korea mouse adapted week housed controlled environmental condition 23–25 40–60 humidity light/dark cycle chow diet water libitum induce colitis mouse salt biomedicals santa ana usa drinking water administered period day followed washout phase using sterile water day sakei hem cfu/200 μl/mouse/day orally administered week treatment day sacrifice mixture ketamine hydrochloride yuhan republic korea xylazine rompun korea branch elanco co. republic korea used anesthetizing sacrificing intraperitoneal route detail composition ketamine/xylazine following 3.2 ketamine hydrochloride 1.4 xylazine 5.4 control group received experimental protocol approved institutional animal care use committee iacuc handong global university approval number hguiacuc 20191008-021 procedure carried compliance arrive guideline guideline animal care use handong global university vivo ova-induced allergic airway inflammation model six-week-old female balb/c mouse housed specific pathogen-free condition allergic airway inflammation induced mouse based previous protocol modification mouse sensitized ovum sigma-aldrich usa aluminum hydroxide alum sigma-aldrich day via intraperitoneal route last sensitization mouse intranasally challenged ovum day day mouse sacrificed serum bronchoalveolar lavage fluid balf lung tissue collected sakei hem cfu/mouse administered via intranasal route first allergen challenge administration performed anesthesia five consecutive day per week week sacrifice mixture ketamine hydrochloride yuhan xylazine rompun korea branch elanco co. used anesthetizing sacrificing experimental protocol approved institutional animal care use committee iacuc handong global university approval number hguiacuc 20190328-013 procedure carried compliance arrive guideline guideline animal care use handong global university histology distal colon left superior lobe mouse lung fixed formaldehyde histological analysis including hematoxylin eosin periodic acid-schiff staining inc. cheongju republic korea commercial service brief fixed tissue embedded paraffin 3-μm-thick slice prepared deparaffinization dehydration staining carried elisa protein level il-4 il-5 balf measured using elisa max™ deluxe set mouse il-4 il-5 biolegend usa according manufacturer protocol serum ige analysis obtained serum stored measured using elisa max™ deluxe set mouse ige biolegend according manufacturer instruction mrna extraction quantitative real-time pcr analysis mrna tissue extracted trizol thermo fischer according manufacturer protocol extracted mrna reverse transcribed complementary dna goscript™ reverse transcription kit promega thermo fischer scientific qrt-pcr performed green™ premix taq kit takara bio japan using step-one plus real-time pcr system applied biosystems usa gene-specific primer acidic ribosomal phosphoprotein arbp β-actin c–c motif chemokine ligand ccl ccl24 claudin cldn cldn cldn cldn cldn interleukin il-6 il-10 il-13 il-17 mucin muc muc5ac occludin ocldn tumor necrosis factor tnf-α zonula occludens-1 zo-1 information primer used listed table amplification process followed reaction condition initial denaturation step min cycle min amplification melting curve analysis carried involving following step heating 0.3 °c/s data quantified comparative threshold cycle method colon data normalized arbp lung data β-actin gene expression short chain fatty acid scfa analysis scfa analysis performed using headspace sampler-gas chromatography-flame ionization detector hss-gc-fid analysis provide brief overview scfas extracted 0.1 mouse fecal sample distilled sample vortexed centrifuged 13,000 rpm min room temperature resulting supernatant transferred vial containing buffer solution 2-ethylbutyric acid added internal standard sample analyzed using agilent 7890b system equipped 7697a headspace sampler fid agilent technology usa data acquisition processing performed using chemstation software agilent technology dna extraction next generation sequencing analysis dna extraction analysis conducted hem pharma inc briefly bacterial dna feces extracted fecal sample homogenized bead-beating isolating cleaning eluting procedure based manufacturer protocol variable v3–v4 region ribosomal rna gene sequenced illumina miseq system illumina sample dna cleaned index pcr carried concentration library verified sequenced using illumina miseq system read sorted using unique barcodes pcr product barcode linker primer sequence eliminated original sequencing read next analysis step bioinformatic analysis single end fastq file imported quantitative insight microbial ecology qiime2 ver 2021.2 via fastq manifest protocol demultiplexed file denoised dada2 amplicon sequence variant aligned mafft plugin phylogeny analysis performed fasttree2 based greengenes database analysis sampling depth reached 19,400 read alpha‐diversity metric shannon index simpson index chao1 index evenness faith phylogenetic diversity beta diversity metric weighted unifrac unweighted unifrac principal coordinate analysis pcoa performed evaluate microbial distance group statistical analysis data analysed graphpad prism software 6.0 9.3.1 graphpad software usa expressed mean statistical significance calculated one-way anova fisher lsd test result isolation identification sakei hem lactic acid bacterial strain isolated vegetable-based kimchi ingredient predominantly identified sakei comparative rrna sequencing among identified isolates strain negative catalase reaction sakei hem selected investigation data shown obtain entire genome information sakei strain hem whole genome sequencing performed genome strain composed circular dna chromosome total size 2,079,011 content 41.2 mol three contigs found varying range 11,771 1,966,385 fig figure circular genome map sakei hem first circle starting inner circle represents genome size second circle indicates content third circle depicts skew c/g fourth circle show number location contigs full size image safety evaluation sakei hem determine safety isolated strain hemolytic activity biogenic amine production antibiotic susceptibility evaluated cereus atcc served positive control hemolysis test sakei hem showed hemolysis reaction biogenic amine production assay strain hem confirmed negative presence precursor amino acid compared positive control coli atcc table strain sakei hem also examined antibiotic susceptibility minimum inhibitory concentration mic value target strain similar compared efsa cut-off value indicating susceptibility tested antibiotic table moreover presence acquired antibiotic resistance gene assessed resfinder program sakei hem confirmed negative resistance gene various class antibiotic table data suggested sakei hem safe human consumption thereby qualified evaluation probiotic candidate adaptability sakei hem git vitro ssdp assay performed determine potential viability sakei hem condition upper git strain exposed simulated stomach- duodenum-like environment sequence counted timepoint sakei hem showed higher survival rate stomach- duodenum-simulated environment pas lgg table additionally adhesion ability strain hem also investigated using caco-2 cell incubation adhesion rate similar lgg table data suggest sakei hem comparable superior adaptability upper git condition probiotic control sakei hem confers protective effect dss-induced colitis evaluate functionality sakei hem vivo system alleviative potential examined dss-induced colitis model oral consumption sakei hem ameliorated body weight loss recovered colon length significantly fig a–c histological specimen showed sakei hem treatment improved deteriorated structure epithelial barrier fig colon sakei hem downregulated mrna expression major pro-inflammatory cytokine fig figure effect oral administration sakei hem mouse dss-induced colitis body weight representative gross appearance colon measurement colon length histopathology distal colon hematoxylin eosin staining relative mrna expression cytokine murine colon tissue measured qrt-pcr ctrl vehicle-treated control vehicle-treated group ls224 sakei hem treated group data show mean 6–8 mouse per group difference compared group analyzed one-way anova fisher lsd test 0.05 0.01 0.001 0.0001 full size image sakei hem improves gut epithelial barrier upregulation tjps gut moreover tjp expression level colon measured strain significantly upregulated main tjp marker fig case mucin gene expression muc4 showed increasing tendency collectively strain may reinforce epithelial barrier integrity upregulation tjps thereby resulting protective effect colitis figure effect sakei hem tight junction protein mucin expression mouse dss-induced colitis relative expression gene regarding tight junction protein murine colon tissue measured qrt-pcr ctrl vehicle-treated control vehicle-treated group ls224 sakei hem treated group data show mean 6–8 mouse per group difference compared group analyzed one-way anova fisher lsd test 0.05 0.01 0.001 0.0001 full size image sakei hem modulates gut microbial metabolite gut microbiota scfa profile three experimental group butyrate production level significantly increased sakei hem 224-treated group suggesting possible modulation gut microbiota table subsequently sakei hem ingestion resulted increased value every alpha diversity index fig microbial community structure analyzed based beta diversity including unweighted weighted unifrac distance represented principal coordinate analysis pcoa plot group presented distinct clustering especially sakei hem treatment group showed clear difference compared group fig taxonomical analysis sakei hem group augmented abundance lactobacillus clostridium specie group data shown microbial data suggest sakei hem induced modulation gut microbiota figure effect oral administration sakei hem microbiota modulation mouse dss-induced colitis bar plot alpha diversity index left shannon simpson chao1 evenness faith principal coordinate analysis pcoa derived unweighted weighted unifrac ctrl vehicle-treated control vehicle-treated group ls224 sakei hem treated group alpha diversity data show mean 3–6 mouse per group difference compared group analyzed one-way anova fisher lsd test 0.05 0.01 0.001 full size image sakei hem ameliorates allergic airway inflammation order ass immunomodulatory effect strain local mucosal organ allergic airway inflammation model induction ovum applied intranasal administration sakei hem successfully decreased il-4 il-5 balf ige serum fig il-13 decreased transcript level significance mrna expression chemokines also altered especially c–c motif chemokine ligand ccl significantly reduced fig histological analysis infiltration inflammatory cell mitigated around alveolus sakei hem treated group fig figure effect intranasal administration sakei hem type inflammation ova-induced allergic airway inflammation murine model th2 cytokine balf ige serum mrna expression type cytokine chemokines lung histology ctrl vehicle-treated control group ovum ovum vehicle-treated group ovum ls224 ovum sakei hem treated group data show mean 3–6 mouse per group difference compared ovum group analyzed one-way anova fisher lsd test 0.05 0.01 0.001 0.0001 full size image sakei hem improves airway epithelial barrier upregulation tjps inhibition mucus hyperproduction lung next effect intranasal treatment sakei hem airway epithelial barrier health evaluated expression tjp gene mucus hypersecretion mrna expression level occludin zo-1 significantly increased compared ovum group moreover muc5ac mrna expression level showed decreasing tendency 0.1719 suggesting improvement epithelial barrier integrity airway fig intranasal treatment sakei hem still showed increased amount mucus along alveolus surface violet intensity alleviated compared ovum group fig result demonstrate intranasal administration sakei hem ameliorated allergic airway inflammation improved airway epithelial barrier health impacting tjp expression mucus hypersecretion figure effect intranasal administration sakei hem tight junction protein mucin expression ova-indued allergic airway inflammation murine model relative mrna expression cytokine murine lung tissue measured qrt-pcr ctrl vehicle-treated control group ovum ovum vehicle-treated group ovum ls224 ovum sakei hem treated group data show mean 3–6 mouse per group difference compared ovum group analyzed one-way anova fisher lsd test 0.05 0.01 0.001 full size image figure effect intranasal administration sakei hem mucus hypersecretion ova-indued allergic airway inflammation murine model image periodic-acid schiff staining original magnification full size image conclusion discussion gut lung posse several similarity connecting overlapped characteristic regarding pathogenesis therefore connection two distinct organ highlighted inflammatory disease site accompany dysregulation immune response also epithelial barrier mucus production reported patient ibd suffer barrier dysfunction reduction goblet cell reduced thickness mucus layer impaired tjps leading increased severity relationship epithelial permeability inflammation similar respiratory system loss dysfunction tjps linked pathogenesis various airway disorder reduced gene expression tjps zo-1 occludin observed inflammatory phenotype airway inflammation vivo model therefore well-tightened epithelial lining might considered key factor protection mucosal disease probiotic suggested alternative treatment various inflammatory disease mucosal site due advantage modulation gut microbiota maturation immune system reinforcement epithelial barrier suggested novel putative probiotic strain sakei hem assessed safety functionality beneficial potential alleviating various mucosal disease study successfully isolated novel sakei strain acquired genomic information whole genome sequencing fig although lab considered safe safety assessment strain level essential determine potential risk consumer biogenic amine formation assay aim evaluate whether tested strain produce specific biogenic amine decarboxylating precursor amino acid test medium biogenic amine exist low concentration nature low consumption doe elicit harmful effect however elevated level diet human body toxic leading health hazard especially sensitive person sakei hem identified negative tested biogenic amine table antibiotic resistance may critical issue especially related presence acquired resistance gene indicating problematic potential transferability sakei hem susceptible tested antibiotic recommended efsa table furthermore presence acquired resistance gene regarding several antibiotic class screened using resfinder program acquired resistance gene detected table regarding functionality evaluation tolerance acidic environment stomach desirable requirement putative probiotic reach intestine ultimately elicit beneficial effect adherence strain gut epithelium closely associated colonization eventually expression beneficial function strain showed notable survivability passage gastric- duodenum-like environment similar attachment ratio intestinal epithelial cell comparable representative commercial probiotic strain lgg vitro study table probiotic potential sakei hem investigated vivo mouse model induced colitis allergic airway inflammation dss-induced colitis model reported closely resemble human ulcerative colitis therefore extensively used ibd research experiment dss-treated mouse showed significant weight loss colon shortening disrupted villus structure histological analysis however sakei hem supported recovery physiology marker fig a–d mrna expression pro-inflammatory cytokine also suppressed il-10 well-known anti-inflammatory regulatory cytokine increased fig reported specific sakei strain modulate immune system boosting number regulatory cell treg il-10 production however strain could influence increase il-10 production colon data shown therefore expected epithelial barrier marker may responsible mechanism tjps exist distal colon decreased level indicate disruption gut barrier loss mucin production lead weakening intestinal barrier increased permeability typical feature ibd study sakei hem increased mrna expression level tjps mucin marker fig data strongly suggest sakei hem reinforce gut barrier integrity upregulation tjps mucin another possible mechanism alleviating colitis mouse modulation gut microbiota reported application probiotic strain could modulate gut microbiota increase diversity ratio bacteroidetes firmicutes eventually attenuated diseased condition study gut microbiota diversity sakei hem treated group increased showed clear clustering beta diversity fig data confirm sakei hem oral administration induced gut microbiota modulation taxonomic analysis show significant difference phylum level however increased abundance lactobacillus clostridium specie observed data shown suggesting strain may modulate gut microbiota contribute forming favorable environment lab bacterial metabolite suggested possible factor strengthening epithelial barrier upregulating tight junction probiotic induce production metabolite scfa stimulate mucin secretion repair tight junction scfas representative effective metabolite directly indirectly affect gut barrier integrity specifically butyrate induce tight junction component gene contributing enhancement epithelial barrier function moreover butyrate production closely related gut microbiota modulation chronic inflammatory state study sakei hem treated mouse showed increased butyrate production specifically scfas table assumed butyrate may involved upregulation tight junction gene gut microbiota modulation well sakei applied gut also local mucosal organ application pulmonary system sparse respiratory tract second-largest mucosal organ git endlessly challenged numerous external factor innate immune system competes inhaled antigen resident infiltrated immune component sustain proper immune tone avoid unwanted airway inflammation however immune balance disrupted various reason including genetic background external influence lead respiratory inflammatory condition inflamed condition infiltrated immune cell worsen response impacting epithelial barrier structurally functionally similar ibd study involving probiotic beneficial microbe proposed potential alternative treatment airway inflammation administration several lactobacillus strain showed alleviative effect including immunomodulation gut microbiota modulation allergic airway inflammation model research probiotic airway inflammation predominantly focused oral administration bacterial strain direct targeting respiratory site become recent focus beneficial effect direct contact observed study sakei strain hem administered intranasally ova-induced allergic airway inflammation model result showed successful suppression th2-related allergic reaction marker improvement physiology observed histological analysis fig interestingly strain applied oral route strain could modulate biased-th2 reaction data shown result indicate treatment sakei hem impact target site direct contact organ another key point study sakei hem upregulated tjp gene expression lung similar colitis result chronic airway inflammation cause airway epithelial damage together downregulation specific tjps sakei hem augmented mrna expression claudin-18 occludin zo-1 lung fig suggesting recovery effect strain impaired epithelial integrity unlike colitis model mucin hypersecretion problematic allergic airway inflammation model muc5ac/ muc5ac representative secretory mucin airway reported marker goblet cell airway surface patient asthma showed abnormal production airway inflammation model intranasal treatment sakei hem downregulated mrna expression muc5ac fig confirmed suppressed production histological analysis fig meaningful sakei hem also affect epithelial barrier health airway still confirmation protein level protein provided bacterial factor responsible reaction need clarified research identified unique novel strain demonstrates beneficial effect two distinct mucosal site particularly intriguing observed beneficial effect disease model dependent route administration case colitis model oral administration sakei hem successfully attenuated colitis modulating gut microbiota however mentioned earlier oral application strain ameliorate allergic airway inflammation based finding hypothesize sakei hem may exert modulatory effect colitis secondary route stimulating change gut microbiota conversely context airway condition allergic inflammation direct contact strain host component may lead different regulatory mechanism nevertheless comprehensive mechanistic study sakei hem regarding intriguing response still warranted application overall study confirmed safety sakei hem use putative probiotic beneficial function evaluated vitro vivo model two inflammatory model targeting gut lung used sakei hem successfully attenuated inflammatory state improvement epithelial barrier component including tjps mucin therefore sakei hem probiotic potential use various mucosal inflammatory disorder